Rod McNeil

Independent Journalist and Consultant

Latest Contribution

Photo showing the PAUL glaucoma drainage device. Image courtesy of Advanced Ophthalmic Innovations.

What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace

1 December 2021 | | Ophthalmology, Glaucoma

Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...

Photo showing Eye-Light device and LLLT Therapy.

Effective management of dry eye and ocular surface disease

4 August 2021 | | Ophthalmology, Optometry

Experts recommend a consistent approach to diagnosis, therapeutic targeting by disease subtype and escalation of therapy when tear substitutes are not sufficient. Experts call for a consistent, unified approach to diagnosis of dry eye disease (DED), with a new simple...

Image of an eye

Post-Brexit deal welcomed but leaves future relationship with EU far from settled

6 April 2021 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Optometry, Ophthalmology, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous

Rod McNeil breaks down the impact of the Brexit deal on healthcare in the UK, including medicines regulation, research funding, sharing of information and the ability to work abroad. A disorderly no-deal exit from the European Union (EU) was averted...